Blood Cancer Kaise Hota Hai: Causes, Types, and Genetic Testing
At a Glance
- Sample Required: Blood sample (peripheral blood) or bone marrow aspirate
- Fasting Rules: Not required
- Turnaround Time (TAT): 3–5 business days
- Base Cost: [Insert Current 2026 Price]
What Is Blood Cancer?
Blood cancer, also known as hematologic malignancy, originates in the bone marrow where blood cells are produced. It disrupts the normal production and function of white blood cells, red blood cells, or platelets. The three main types are leukemia, lymphoma, and myeloma. Each type has distinct characteristics, but all involve uncontrolled growth of abnormal cells.
Types of Blood Cancer
Understanding the specific type is crucial for treatment decisions. The table below summarizes the primary categories:
| Type | Origin | Common Subtypes |
|---|---|---|
| Leukemia | Bone marrow – white blood cells | Acute lymphocytic (ALL), Acute myeloid (AML), Chronic lymphocytic (CLL), Chronic myeloid (CML) |
| Lymphoma | Lymphatic system – lymphocytes | Hodgkin lymphoma, Non-Hodgkin lymphoma |
| Myeloma | Plasma cells in bone marrow | Multiple myeloma |
Causes and Risk Factors
The exact cause of blood cancer is often unknown, but several risk factors have been identified:
- Genetic mutations: Acquired or inherited mutations in genes such as TP53, RUNX1, or JAK2 can predispose individuals to hematologic malignancies.
- Exposure to radiation: High-dose radiation, including previous cancer therapy, increases risk.
- Chemical exposure: Benzene and certain chemotherapy agents are linked to leukemia.
- Family history: A first-degree relative with blood cancer raises the risk.
- Age and gender: Some types are more common in children (ALL) or older adults (CLL, myeloma).
Genetic Testing in Blood Cancer
Modern diagnostics rely on Next-Generation Sequencing (NGS) and Whole Exome Sequencing (WES) to identify specific mutations that guide targeted therapy and prognosis. Unlike older Sanger sequencing, NGS can simultaneously analyze multiple genes, providing a comprehensive genomic profile. DNA Labs India offers advanced genetic testing to detect hereditary predispositions and somatic mutations.
For hereditary cases, germline testing can identify inherited mutations that increase susceptibility. This is particularly relevant when multiple family members are affected or when the patient is young.
Symptoms and Clinical Presentation
Symptoms vary by type but often include fatigue, recurrent infections, easy bruising, unexplained weight loss, and swollen lymph nodes. The following timeline outlines typical progression:
| Phase | Symptoms | Typical Duration |
|---|---|---|
| Early | Fatigue, low-grade fever, night sweats | Weeks to months |
| Progressive | Pallor, recurrent infections, easy bruising | Months |
| Advanced | Bone pain, weight loss, enlarged spleen or liver | Variable |
Diagnosis and Laboratory Testing
Diagnosis typically begins with a complete blood count (CBC) and peripheral blood smear. If abnormal cells are detected, bone marrow biopsy and flow cytometry are performed. Genetic testing using NGS or WES is now standard to identify actionable mutations. Molecular diagnostics like RT-PCR are used for minimal residual disease monitoring.
At DNA Labs India, we provide comprehensive hematologic panels that include cytogenetic analysis, FISH, and NGS-based mutation profiling. Our ISO 9001 certified laboratory ensures accurate and timely results.
Treatment Overview
Treatment depends on the type and stage. Options include chemotherapy, radiation, targeted therapy, immunotherapy, and stem cell transplantation. Genetic testing results guide the choice of targeted agents, improving outcomes and reducing side effects.
When to Consult a Doctor
If you experience persistent fatigue, unexplained fever, night sweats, or unexplained weight loss, seek medical evaluation. Early detection significantly improves prognosis. For individuals with a family history of blood cancer, genetic counseling and testing are recommended.
Frequently Asked Questions
Is blood cancer hereditary?
Most blood cancers are not directly inherited, but certain genetic mutations can increase susceptibility. Hereditary syndromes like Li-Fraumeni or familial CLL account for a small percentage of cases.
Can blood cancer be detected early?
Routine blood tests may reveal abnormalities, but there is no standard screening for all types. Genetic testing can identify high-risk individuals.
Written by: Dr. Ananya Sharma, MBBS, MD (Pathology)
Medically Reviewed by: Dr. Rajesh Kumar, DM (Clinical Hematology)
Last Updated: February 2026